SK121293A3 - Ingestible pharmaceutical compositions for treating upper gastrointestinal tract disorder - Google Patents

Ingestible pharmaceutical compositions for treating upper gastrointestinal tract disorder Download PDF

Info

Publication number
SK121293A3
SK121293A3 SK1212-93A SK121293A SK121293A3 SK 121293 A3 SK121293 A3 SK 121293A3 SK 121293 A SK121293 A SK 121293A SK 121293 A3 SK121293 A3 SK 121293A3
Authority
SK
Slovakia
Prior art keywords
magnesium
aluminum
bismuth
carbonate
oral pharmaceutical
Prior art date
Application number
SK1212-93A
Other languages
English (en)
Slovak (sk)
Inventor
James G Upson
Carmelita M Russell
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of SK121293A3 publication Critical patent/SK121293A3/sk

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
SK1212-93A 1991-04-04 1992-03-13 Ingestible pharmaceutical compositions for treating upper gastrointestinal tract disorder SK121293A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68045991A 1991-04-04 1991-04-04
PCT/US1992/001981 WO1992017164A1 (en) 1991-04-04 1992-03-13 Ingestible pharmaceutical compositions for treating upper gastrointestinal tract distress

Publications (1)

Publication Number Publication Date
SK121293A3 true SK121293A3 (en) 1994-07-06

Family

ID=24731206

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1212-93A SK121293A3 (en) 1991-04-04 1992-03-13 Ingestible pharmaceutical compositions for treating upper gastrointestinal tract disorder

Country Status (16)

Country Link
EP (1) EP0578768B1 (hu)
JP (1) JPH06506682A (hu)
KR (1) KR100238565B1 (hu)
AT (1) ATE128351T1 (hu)
AU (1) AU665349B2 (hu)
BR (1) BR9205827A (hu)
CA (1) CA2106215C (hu)
CZ (1) CZ282105B6 (hu)
DE (1) DE69205158T2 (hu)
DK (1) DK0578768T3 (hu)
ES (1) ES2077417T3 (hu)
GR (1) GR3017580T3 (hu)
HU (1) HU213203B (hu)
RU (1) RU2126249C1 (hu)
SK (1) SK121293A3 (hu)
WO (1) WO1992017164A1 (hu)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08502288A (ja) * 1992-10-09 1996-03-12 ザ、プロクター、エンド、ギャンブル、カンパニー 感昌症状を治療するための医薬組成物及び用法
GB9221414D0 (en) * 1992-10-13 1992-11-25 Glaxo Group Ltd Pharmaceutical compositions
WO1994025009A1 (en) * 1993-04-30 1994-11-10 The Procter & Gamble Company Coated pharmaceutical compositions
PT698393E (pt) * 1993-05-19 2002-10-31 Hisamitsu Pharmaceutical Co Agente de solubilizacao e preparacao para uso externo contendo o mesmo
AU7565594A (en) * 1993-08-17 1995-03-14 Applied Analytical Industries, Inc. Oral compositions of h2-antagonists
US5451401A (en) * 1993-09-29 1995-09-19 The Procter & Gamble Company Diphosphonic acid esters as tartar control agents
US5762962A (en) * 1994-10-05 1998-06-09 Warner-Lambert Company Antacid pharmaceutical composition
EP0725630A1 (en) * 1993-10-28 1996-08-14 The Procter & Gamble Company Fast dissolving dosage forms containing magnesium aluminum silicate and multiple active ingredients
US5399356A (en) * 1994-03-24 1995-03-21 The Procter & Gamble Company Process for making solid dose forms containing bismuth
WO1995025521A1 (en) * 1994-03-24 1995-09-28 The Procter & Gamble Company Solid dose forms containing bismuth
CO4410201A1 (es) * 1994-07-20 1997-01-09 Colgate Palmolive Co Metodos y composiciones farmaceuticas para el tratamiento de transtornos gastricos
US5713131A (en) * 1995-06-30 1998-02-03 The Gillette Company Shaving aid composite with a non-volatile cooling agent
DE19529862A1 (de) * 1995-08-14 1997-02-20 Rhone Poulenc Rorer Gmbh Pharmazeutische, oral anwendbare Zubereitung
IL230419A0 (en) * 2013-05-23 2014-04-30 Naveh Pharma 1996 Ltd Products containing magnesium and their uses

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1353381A (en) * 1971-02-04 1974-05-15 Wilkinson Sword Ltd Substituted p-menthanes and compositions containing them
US4060091A (en) * 1972-01-28 1977-11-29 Wilkinson Sword Limited Tobacco and tobacco-containing manufactures containing an ingredient having physiological cooling activity
JPS5888334A (ja) * 1981-11-20 1983-05-26 Takasago Corp 3−l−メントキシプロパン−1、2−ジオ−ル

Also Published As

Publication number Publication date
GR3017580T3 (en) 1995-12-31
RU2126249C1 (ru) 1999-02-20
DK0578768T3 (da) 1996-02-05
ES2077417T3 (es) 1995-11-16
AU1761492A (en) 1992-11-02
HUT65881A (en) 1994-07-28
DE69205158D1 (de) 1995-11-02
HU9302970D0 (en) 1994-01-28
JPH06506682A (ja) 1994-07-28
CA2106215C (en) 1997-05-27
CA2106215A1 (en) 1992-10-05
WO1992017164A1 (en) 1992-10-15
EP0578768B1 (en) 1995-09-27
HU213203B (en) 1997-03-28
CZ282105B6 (cs) 1997-05-14
DE69205158T2 (de) 1996-04-18
AU665349B2 (en) 1996-01-04
ATE128351T1 (de) 1995-10-15
EP0578768A1 (en) 1994-01-19
CZ226093A3 (en) 1994-04-13
BR9205827A (pt) 1994-06-28
KR100238565B1 (ko) 2000-02-01

Similar Documents

Publication Publication Date Title
US5244670A (en) Ingestible pharmaceutical compositions for treating upper gastrointestinal tract distress
US5629013A (en) Chewable calcium carbonate antacid tablet compositions
EP1077726B1 (en) Inhibiting undesirable taste in oral compositions
US5989588A (en) Methods and compositions for preventing and treating heartburn
EP1807068B1 (en) Composition comprising acetaminophen, caffeine and aspirin together with an alkiline agent fr enhanced absorption
SK121293A3 (en) Ingestible pharmaceutical compositions for treating upper gastrointestinal tract disorder
EP0578732B1 (en) Chewable antacid compositions
KR100846945B1 (ko) 파라세타몰을 포함하는 연하 정제
US5762962A (en) Antacid pharmaceutical composition
KR20070034576A (ko) 록소프로펜을 함유하는 경구 투여용 조성물
JPH0656677A (ja) 制酸剤組成物
CA2184361C (en) Solid dose forms containing bismuth
US4446132A (en) Nontoxic aspirin composition
WO1996008238A1 (en) Use of paracellular absorption enhancers such as glucose for enhaincing the absorption of histamine h2-antagonists
ES2274550T3 (es) Procedimientos y composiciones para prevenir y tratar ardor de estomago.
WO1998024455A1 (en) Ingestible pharmaceutical compositions for treating upper gastrointestinal tract distress
WO1999010000A1 (en) Combined preparations for treating upper gastrointestinal tract distress
WO2010067151A1 (en) Quick disintegrating taste masked composition
JP2021070685A (ja) 固形製剤
MX2007007146A (es) Composicion antiacida y refrescante del aliento.
MXPA99001598A (en) Inhibiting undesirable taste in oral compositions
CZ76996A3 (en) Pharmaceutical composition
NZ243613A (en) Tablet comprising praziquantel, pyrantel pamoate and oxantel pamoate in synergistic proportions for treatment of nematode infestations